FGF23‐mediated hypophosphatemia following saccharated ferric oxide administration during nutritional rehabilitation in anorexia nervosa: A case report
Psychiatry and Clinical Neurosciences Reports · 2026-12 · 5 (4)
DOI: 10.1002/pcn5.70448 ↗Kurz gefasst
Fallbericht in der Zeitschrift Psychiatry and Clinical Neurosciences Reports, online erschienen am 18.11.2026. Verfasst von Yukia Nishiue und 6 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hypophosphatemia is a clinically important complication of nutritional rehabilitation in patients with anorexia nervosa (AN). Refeeding‐related hypophosphatemia is often suspected initially. However, persistent hypophosphatemia despite phosphate supplementation or an atypical biochemical pattern should prompt evaluation for alternative causes. Intravenous iron is a recognized cause of fibroblast growth factor 23 (FGF23)‐mediated hypophosphatemia. However, longitudinal documentation of intact FGF23 and renal phosphate handling before and after intravenous iron exposure during nutritional rehabilitation for severe AN remains limited. Case Presentation A 17‐year‐old female with restricting‐type AN and severe malnutrition (body mass index, 13.2 kg/m 2 ) was admitted for nutritional rehabilitation. She had severe iron‐deficiency anemia and received intravenous saccharated ferric oxide. Hypophosphatemia developed despite prophylactic phosphate supplementation and persisted despite escalation of oral supplementation and the addition of intravenous phosphate replacement. Refeeding‐related hypophosphatemia was initially suspected. However, the percentage tubular reabsorption of phosphate (%TRP) and tubular maximum reabsorption of phosphate per glomerular filtration rate (TmP/GFR) were markedly reduced during hypophosphatemia, indicating inappropriate renal phosphate wasting. Serial measurements demonstrated a transition from a normal pre‐exposure intact FGF23 concentration (36.4 pg/mL) to marked FGF23 excess (782–838 pg/mL), followed by a progressive decline after iron withdrawal. Serum phosphate gradually recovered. No symptoms or organ dysfunction attributable to hypophosphatemia occurred.
Conclusion
Hypophosphatemia during nutritional rehabilitation in AN should not automatically be attributed to refeeding‐related mechanisms. Persistent hypophosphatemia despite supplementation, particularly when accompanied by renal phosphate wasting, should prompt reassessment of the underlying mechanism and evaluation for FGF23‐mediated hypophosphatemia in patients exposed to intravenous iron.
Zitieren
APA
Nishiue, Y., Nishimoto, K., Harada, T., Nagata, Y., Kurajoh, M., Matsuzuka, T., & Inoue, K. (2026). FGF23‐mediated hypophosphatemia following saccharated ferric oxide administration during nutritional rehabilitation in anorexia nervosa: A case report. Psychiatry and Clinical Neurosciences Reports, 5(4). https://doi.org/10.1002/pcn5.70448
Vancouver
Nishiue Y, Nishimoto K, Harada T, Nagata Y, Kurajoh M, Matsuzuka T, et al. FGF23‐mediated hypophosphatemia following saccharated ferric oxide administration during nutritional rehabilitation in anorexia nervosa: A case report. Psychiatry and Clinical Neurosciences Reports. 2026;5(4). doi:10.1002/pcn5.70448
BibTeX
@article{Nishiue2026,
author = {Nishiue, Yukia and Nishimoto, Kazuya and Harada, Tomoko and Nagata, Yuki and Kurajoh, Masafumi and Matsuzuka, Takumi and Inoue, Koki},
title = {FGF23‐mediated hypophosphatemia following saccharated ferric oxide administration during nutritional rehabilitation in anorexia nervosa: A case report},
journal = {Psychiatry and Clinical Neurosciences Reports},
year = {2026},
volume = {5},
number = {4},
doi = {10.1002/pcn5.70448}
}
EUVIMED